The finding of high burden of SCD in carriers of NKX2-5 truncating variants highlights the need for genetic testing as well as close clinical follow up for best medical management in pateints suspected to have the disease. The gene discussed is NKX2-5; the disease is Schnyder corneal dystrophy.